Pay in 4 interest-free payments of $6.83 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
NICE first recommended the drug in draft guidance 2022, after a clinical trial of just under 2000 volunteers found that people lost on average 12% more weight with semaglutide alongside supervised weight loss coaching (BMJ 2023;380:556)
Our results also revealed that exogenous Cys further increased the expression of GSH synthesis related genes GS1 and GS2
([PubMed][1]) 2
GLP-1 receptor agonists are among the most clinically significant drugs to reach mainstream use in a generation
"The HCSC transaction closed later than the company's financial planning assumptions, increasing the first quarter Cigna Healthcare [MLR] as the Medicare businesses operate at a higher [MLR] compared to the rest of the portfolio," the company wrote in its filing
US$ 29.24
US$ 21.26
US$ 28.82
US$ 22.18
US$ 26.46
US$ 21.60
US$ 25.05
US$ 25.32
US$ 25.21
